Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Purpose: This study aimed to investigate the effects of an expandable implant (EI) in ovariectomized sheep.
Methods: The EI and taper implant (control group) were produced and placed in mandibles of ovariectomized sheep. Twelve weeks after implantation, resonance frequency analysis, biomechanical tests, histomorphometry, and micro-computed tomography were applied to detect the osseointegration in the 2 groups.
Results: The implant stability quotient values, maximal pullout forces, and bone-implant contact (BIC) were 60.3 ± 7.9, 511.0 ± 18.7 N, and 53.14% ± 4.56%, respectively, in the EI group and 58.3 ± 8.9, 394.5 ± 54.5 N, and 46.85% ± 5.04%, respectively, in the control group. There was no significant difference between the 2 groups in implant stability quotient values (P > .05); however, in the EI group the maximal pullout force and BIC were increased significantly (P < .05 and P < .01, respectively). Micro-computed tomography analysis showed that the bone volume/total volume ratio and trabecular number increased significantly (P < .01) and trabecular separation decreased significantly (P < .05) in the EI group.
Conclusions: EI could improve osseointegration in osteoporosis after 12 weeks of implantation by increasing BIC around the implant and by supplying an extra osseointegration surface.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.joms.2012.10.018 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
IFN-γ Targeting the JAK2/STAT3-METTL3 Pathway Ameliorates Mandibular Osteogenic Differentiation in Postmenopausal Rats.
FASEB J
September 2025
School and Hospital of Stomatology, Zunyi Medical University, Zunyi City, Guizhou Province, China.
To investigate whether interferon-gamma (IFN-γ) alleviates postmenopausal osteoporosis (POP) by regulating METTL3 via the JAK2/STAT3 pathway to enhance osteogenic differentiation of jawbone marrow stromal cells (JBMSCs). Ovariectomized (OVX) rats received IFN-γ (5000 IU/dose, 3×/week for 24 weeks), with jawbone mass assessed via micro-CT and HE staining. JBMSCs were cultured, and osteogenic differentiation under IFN-γ (optimal concentration: 10 ng/mL) was evaluated using qRT-PCR, ALP/alizarin red staining, and CCK-8.
View Article and Find Full Text PDFEffects of Ovariectomy and Low-Calcium Diet on Six Different Sites of the Rat Skeleton.
Biomimetics (Basel)
July 2025
Laboratory of Experimental Surgery and Surgical Research "N.S. Christeas", School of Medicine, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
The aim of this study was to evaluate structural and micro-architectural changes in the mandible, parietal bone, femur, and tibia in OVX rats at different time periods after ovariectomy. Forty-two 11-month-old female Wistar rats were used. Six rats without surgery were euthanized to serve as a baseline.
View Article and Find Full Text PDFMultiscale characterization of jawbone treated with osteoporosis therapeutic agents.
J Mech Behav Biomed Mater
September 2025
Division of Orthodontics, College of Dentistry, The Ohio State University, Columbus, OH,USA. Electronic address:
The objective of the current study was to determine whether treatments of bisphosphonate (alendronate (ALN)), parathyroid hormone (PTH), and their combination have an effect on the jawbone in estrogen deficient rats. Six female rats (4-month-old) were used for each sham surgery (SHAM). Twenty-four rats (4-month-old) were ovariectomized and randomly assigned to four equal groups: saline injection (VEH), PTH following saline injection (VEH/PTH), bisphosphonate (ALN), or a combination (ALN/PTH).
View Article and Find Full Text PDFOmega-3 attenuates the severity of medication-related osteonecrosis of the jaws in rats treated with zoledronate.
PLoS One
May 2025
Nucleus of Study and Research in Periodontics and Implantology (NEPPI), School of Dentistry, São Paulo State University (Unesp), Araçatuba, São Paulo, Brazil.
This study aimed to evaluate the ability of ω-3 to modulate the tissue response in rats with MRONJ, focusing on histopathological and immunohistochemical parameters. Forty Wistar rats were subjected to bilateral ovariectomy and, three months later, the medication regimen with ZOL (100μg/kg; groups ZOL and ZOL-ω3) of vehicle (VEH and VEH-ω3) was initiated. Following 3 weeks of ZOL or VEH, experimental periodontitis was induced around the mandibular left first molars of all animals.
View Article and Find Full Text PDFSexual Dimorphism in the Musculoskeletal System: Sex Hormones and Beyond.
J Endocr Soc
August 2024
Department of Anatomy, Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, IN 46202-5120, USA.
Mounting evidence indicates that whereas some fundamental aspects of bone cell differentiation and function are similar in females and males, there is a clear contribution of sex/gender on the effects of signaling molecules on bone mass and strength and, consequently, on the effects of pharmacologic approaches to treat skeletal disorders. However, until recently, most studies were designed and performed using only 1 sex, resulting in a scarcity of published information on sexual dimorphism of the musculoskeletal system, including the mandible/masticatory muscles and the axial and appendicular bones and skeletal muscles. Further, it is now recognized that scientific rigor requires the study of both males and females.
View Article and Find Full Text PDF